Geron Corporation

Symbol: GERN




Market price today

  • -6.3426

    P/E Ratio

  • -0.0633

    PEG Ratio

  • 1.04B

    MRK Cap

  • 0.00%

    DIV Yield

Geron Corporation (GERN) Stock Price & Analysis

Shares Outstanding


Gross Profit Margin


Operating Profit Margin


Net Profit Margin


Return on Assets


Return on Equity


Return on Capital Employed


Company general description and statistics

Sector: Healthcare
Industry: Biotechnology
CEO:Dr. John A. Scarlett M.D.
Full-time employees:107
City:Foster City
Address:919 East Hillsdale Boulevard

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hematologic myeloid malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.

General Outlook

In simple terms, Geron Corporation has 543.064 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 1.000% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -572.890%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -550.511%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -0.423% return, is a testament to Geron Corporation's adeptness in optimizing resource deployment. Geron Corporation's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -0.701%. Furthermore, the proficiency of Geron Corporation in capital utilization is underscored by a remarkable -0.561% return on capital employed.

Stock Prices

Geron Corporation's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $1.955, while its low point bottomed out at $1.88. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Geron Corporation's stock market.
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2023?

There are stock number shares outstanding of Geron Corporation (GERN) on the NASDAQ in 2023.

What is P/E ratio of enterprise in 2023?

The current P/E ratio of enterprise is -6.343 in 2023.

What is the ticker symbol of Geron Corporation stock?

The ticker symbol of Geron Corporation stock is GERN.

What is company IPO date?

IPO date of Geron Corporation is 1996-07-31.

What is company current share price?

Current share price is 1.910 USD.

What is stock market cap today?

The market cap of stock today is 1037252240.000.

What is PEG ratio in 2023?

The current -0.063 is -0.063 in 2023.

What is the number of employees in 2023?

In 2023 the company has 107.